Agenus meldet überzeichnete Privatplatzierung von bis zu 340 Millionen US-Dollar zur Weiterentwicklung der zulassungsrelevanten ROBBIN-Studie mit neoadjuvantem BOT+BAL bei MSS-Kolonkarzinom
Wednesday, July 15, 2026 BiopharmaWatch Research 1 min read
Key Takeaway: Agenus Inc. has successfully completed a private placement agreement, raising approximately $85 million, with the potential to secure an additional $255 million through the exercise of warrants. This funding is intended to support the development of the pivotal ROBBIN study, focusing on neoadjuvant BOT+BAL for MSS colon cancer. The financing was led by Commodore Capital.
Price reaction · baseline $4.895 (2026-07-15T18:03:00.000Z) · hit during market hours · 1 other AGEN headline(s) in the window, move may be shared
day 0 close · peak
+2.3%
Market Sentiment Analysis
POSITIVE FACTORS
Successful private placement of $85 million announced.
Potential for an additional $255 million through warrants.
Funding aimed at advancing the pivotal ROBBIN study.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
3.1%
average across 3 past catalysts
Cash runway
~0 mo
High dilution risk
Lead asset
Botensilimab
Phase 2 · Early Rectal Cancer
Full Press Release Details
LEXINGTON, Massachusetts, USA--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), ein führendes Unternehmen im Bereich der immunonkologischen Innovation, gab heute den Abschluss eines Wertpapierkaufvertrags über eine Privatplatzierung mit einem Bruttoerlös von rund 85 Millionen US-Dollar im Voraus – vor Abzug der Kosten der Privatplatzierung – sowie bis zu weiteren 255 Millionen US-Dollar bei vollständiger Ausübung der Kaufoptionsscheine bekannt. Angeführt wurde die Finanzierungsrunde von Commodore C
Frequently Asked Questions
What is the total funding amount for Agenus?
Agenus has secured a total funding of up to $340 million.
What study is the funding aimed to support?
The funding is intended to advance the pivotal ROBBIN study.
How much was raised in the initial private placement?
Agenus raised approximately $85 million in the initial private placement.